Jeisys Medical Future Growth
Future criteria checks 5/6
Jeisys Medical is forecast to grow earnings and revenue by 29.7% and 17.2% per annum respectively. EPS is expected to grow by 29.7% per annum. Return on equity is forecast to be 31% in 3 years.
Key information
29.7%
Earnings growth rate
29.7%
EPS growth rate
| Medical Equipment earnings growth | 35.5% |
| Revenue growth rate | 17.2% |
| Future return on equity | 31.0% |
| Analyst coverage | Good |
| Last updated | 13 May 2024 |
Recent future growth updates
Recent updates
Jeisys Medical Inc. (KOSDAQ:287410) Looks Just Right With A 31% Price Jump
May 25
Is There An Opportunity With Jeisys Medical Inc.'s (KOSDAQ:287410) 46% Undervaluation?
May 21The Returns On Capital At Jeisys Medical (KOSDAQ:287410) Don't Inspire Confidence
Apr 27Jeisys Medical Inc. (KOSDAQ:287410) Looks Just Right With A 28% Price Jump
Apr 09Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 256,652 | 62,097 | 59,000 | 60,333 | 5 |
| 12/31/2025 | 216,427 | 50,686 | 27,540 | 49,680 | 7 |
| 12/31/2024 | 185,734 | 39,915 | 39,000 | 42,900 | 5 |
| 3/31/2024 | 157,881 | 25,045 | 18,655 | 33,453 | N/A |
| 12/31/2023 | 143,030 | 24,800 | 17,660 | 32,678 | N/A |
| 9/30/2023 | 135,176 | 26,795 | 30,400 | 34,383 | N/A |
| 6/30/2023 | 124,711 | 26,057 | 24,864 | 35,565 | N/A |
| 3/31/2023 | 120,320 | 27,260 | 18,761 | 30,063 | N/A |
| 12/31/2022 | 116,550 | 27,130 | 11,739 | 25,251 | N/A |
| 9/30/2022 | 109,141 | 29,212 | 8,864 | 21,623 | N/A |
| 6/30/2022 | 100,904 | 28,379 | 14,188 | 20,219 | N/A |
| 3/31/2022 | 89,372 | 26,445 | 16,593 | 21,861 | N/A |
| 12/31/2021 | 81,296 | 13,860 | 17,517 | 20,301 | N/A |
| 9/30/2021 | 69,247 | 6,907 | 12,691 | 15,674 | N/A |
| 6/30/2021 | 64,028 | 6,778 | 15,889 | 18,595 | N/A |
| 3/31/2021 | 53,426 | -1,318 | 13,318 | 16,475 | N/A |
| 12/31/2020 | 47,829 | 7,151 | 13,146 | 16,123 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A287410's forecast earnings growth (29.7% per year) is above the savings rate (2.5%).
Earnings vs Market: A287410's earnings (29.7% per year) are forecast to grow faster than the KR market (29.1% per year).
High Growth Earnings: A287410's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: A287410's revenue (17.2% per year) is forecast to grow faster than the KR market (10.4% per year).
High Growth Revenue: A287410's revenue (17.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A287410's Return on Equity is forecast to be high in 3 years time (31%)